Amoéba is developing biological fungicides for treating diseases such as mildews and rusts, which have a major economic impact on the production globally of a wide range of crops. These novel fungicides are based on the characteristics of the Willaertia magna C2c Maky amoeba.

According to a report from Grand View Research, the global crop protection chemicals market was valued at $43.2bn in 2022 and is expected to expand at a CAGR of 5.6% from 2023 to 2030. Within this market, the biological segment is growing rapidly. A report published by P&S Intelligence noted that the global biocontrol agents market was worth c $4.9bn in 2021, and predicted that it would increase to $13.6bn by 2030 (CAGR of 12.2% from 2021 to 2030). Management estimates that Amoéba’s addressable market size within the biological agents market is €1.6bn, expanding to €8bn if conventional fungicides are replaced by biological ones.